Back to VRCA
Capital Analysts, LLC VRCA Position History
Verrica Pharmaceuticals Inc. • Healthcare
Quarters held
14
Latest value
$7K
Q3 2026
Peak value
$12K
First seen
Q3 2024
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2024 | $9K |
| Q4 2024 | $9K |
| Q1 2025 | $7K |
| Q2 2025 | $11K |
| Q3 2025 | $6K |
| Q3 2025 | $6K |
| Q4 2025 | $12K |
| Q4 2025 | $12K |
| Q4 2025 | $12K |
| Q1 2026 | $8K |
| Q1 2026 | $8K |
| Q2 2026 | $9K |
| Q2 2026 | $9K |
| Q3 2026 | $7K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $7K | 1.5K | — | — |
| Q2 2026 | $9K | 1.5K | — | — |
| Q2 2026 | $9K | 1.5K | — | — |
| Q1 2026 | $8K | 1.5K | — | — |
| Q1 2026 | $8K | 1.5K | — | — |
| Q4 2025 | $12K | 1.5K | — | — |
| Q4 2025 | $12K | 1.5K | — | — |
| Q4 2025 | $12K | 1.5K | — | — |
| Q3 2025 | $6K | 1.5K | — | — |
| Q3 2025 | $6K | 1.5K | — | — |
| Q2 2025 | $11K | 21.3K | — | — |
| Q1 2025 | $7K | 16.3K | — | — |
| Q4 2024 | $9K | 13.3K | — | — |
| Q3 2024 | $9K | 6.3K | — | — |
Other funds holding VRCA
$11M
$8.9M
$8.8M
$8.1M
$7.7M
$6.7M